Please assess the completion status of the following clinical trial:

Trial Title: Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: ECOLOGIC_OR_COMMUNITY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Aged 18 years or older;~* Have a smartphone;~* Understand and read English;~* Will be on one production location for at least three weeks following enrollment to the study;~* Will be willing to be contacted by the Study Coordinator after leaving one production location to facilitate continued access to weekly molecular testing;~Exclusion Criteria:~* Have received any dose of COVID-19 vaccination;~* Have been diagnosed with COVID-19 infection.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).